Prosight Management, LP - CARA THERAPEUTICS INC ownership

CARA THERAPEUTICS INC's ticker is CARA and the CUSIP is 140755109. A total of 162 filers reported holding CARA THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.60 and the average weighting 0.2%.

Quarter-by-quarter ownership
Prosight Management, LP ownership history of CARA THERAPEUTICS INC
ValueSharesWeighting
Q1 2021$2,171,000
-51.2%
100,000
-66.0%
1.78%
-13.5%
Q4 2020$4,449,000
+100.2%
294,041
+68.4%
2.06%
+94.5%
Q3 2020$2,222,000
+49.4%
174,644
+100.8%
1.06%
+65.7%
Q2 2020$1,487,00086,9650.64%
Other shareholders
CARA THERAPEUTICS INC shareholders Q3 2020
NameSharesValueWeighting ↓
RHO CAPITAL PARTNERS INC 3,568,057$70,005,00074.08%
Chescapmanager LLC 1,203,055$23,604,0002.80%
Mesirow Financial Investment Management, Inc. 29,821$585,0002.32%
DAFNA Capital Management LLC 143,611$2,818,0001.22%
Opaleye Management Inc. 200,000$3,924,0001.09%
SPHERA FUNDS MANAGEMENT LTD. 303,930$5,963,0000.54%
DISCIPLINED GROWTH INVESTORS INC /MN 852,892$16,734,0000.29%
DLD Asset Management, LP 352,700$6,927,0000.26%
SHANDA ASSET MANAGEMENT HOLDINGS Ltd 54,984$1,079,0000.18%
B. Riley Wealth Management, Inc. 33,755$662,0000.12%
View complete list of CARA THERAPEUTICS INC shareholders